Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15 by Camp, G. van et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/20568
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
© 1995 Oxford University Press Human Molecular Geneticst 1995, Vol. 4, No. Il 2159-2163
Localization of a gene for non-syndromic hearing loss 
(DFNA5) to chromosome 7p15
Guy Van Camp*, Paul Coucke, Wendy Balemans, Désirée Van Velzen, Caroline Van de Blit1, Lut Van Laer,
Richard J.H.Smith , Kunihiro Fukushima2, George W.Padberg3, Rune R.Frants4, Paul Van de Heyning5, Shelley D.Smith6, 
Egbert H.Huizing1 and Patrick J.WiUems
Department of Medical Genetics, University of Antwerp (UIA), Universiteitsplein 1, 2610 Antwerp, Belgium, 1ENT Department, University
Hospital Ulrecht, PO box 85500, 3508 GA Utrecht, The Netherlands, departm ent of Otolaryngology, University of Iowa Hospitals and Clinics,
650 Newton Road, E230 GH Iowa City, Iowa 52242, USA, department of Neurology, Catholic University Nijmegen, PO Box 9101, 6500 HB
Nijmegen, Medical Genetics Center, Leiden University, Wassenaarseweg 72, 2333 Leiden, The Netherlands, 5ENT Department, University of
Antwerp (UIA), Universiteitsplein 1, 2610 Antwerp, Belgium and 8Center for Hereditary Communication Disorders, Boys Town National Research 
Hospital, 555 North Street, Omaha, Nebraska 68131, USA
Received May 24, 1995; Revised and Accepted August 21, 1995
Progressive hearing loss affects approximately 50% 
of the elderly by the age of 80, and is most likely 
caused by an interaction of genetic and environmental 
factors. Identification of the genes responsible for 
hereditary hearing loss is therefore important. Famil­
ies with pure genetic degenerative hearing disorders 
may be helpful as the same genes may be also 
involved in age-related hearing loss in general. In this 
study we have performed a genome search in an 
extended Dutch family with autosomal dominant pro­
gressive hearing loss starting in the high frequencies. 
The gene causing hearing loss in this family was 
localized to the short arm of chromosome 7, in a 
15 cM interval between markers D7S493 and D7S632.
INTRODUCTION
Hearing impairment is one of the most frequent handicaps in 
the Western world. Two groups can be distinguished: pre- 
lingual and post-lingual hearing loss. Approximately 1/1000 
children is born deaf. About half of these cases is caused by 
genetic factors, which makes pre-lingual deafness one of the 
most frequent genetic conditions (1-3). However, only a small 
part of hearing loss in the total population is due to pre- 
lingual deafness, and the percentage of adults with a hearing 
impairment increases significantly with age. Hearing loss of 
more than 25 dB is present in approximately 1% of young 
adults between 18 and 24 years, in approximately 10% of the 
individuals between 55 and 64, and in approximately 50% of 
the elderly between 75 and 80 (3).
The causes of progressive hearing Loss starting in adulthood 
are unknown in most cases. In many instances, this type of 
progressive hearing impairment is most likely caused by an 
interaction of different genes and environmental factors. A 
single cause can be identified only in a minority of cases. In 
some patients a specific environmental factor such as noise, 
trauma, infection or an ototoxic drug is known to be responsible 
for the hearing loss. On the other hand, a number of families 
have been reported with a clear autosomal dominant progress­
ive hearing loss (4). In some of these families, hearing 
impairment is present in many family members, thereby 
facilitating gene localization studies by linkage analysis. These 
families present a unique opportunity for the identification of 
genes involved in progressive hearing loss. The same genes 
may be involved in both pure genetic hearing loss and hearing 
deterioration due to a combination of genetic? and environmental 
factors. An example of such a gene is the mitochondrial 
ribosomal RNA gene, for which it is known that the same 
mutation gives rise to familial susceptibility to aminoglycoside- 
induced deafness in some families, and non-syndromic pre- 
lingual deafness in another family (5). In time, the identification 
of genes for pure genetic progressive hearing loss will lead to 
a better insight into the mechanisms causing hearing deteriora­
tion in general. These mechanisms may provide a useful model 
for certain types of age-related hearing loss.
Many studies on the etiology of pre-lingual hearing loss 
have been carried out. More than 70% of pre-lingual hereditary 
deafness is non-syndromic, and not associated with any other 
clinical abnormality (1,6). Non-syndromic pre-lingual hearing 
loss is genetically heterogeneous and it has been estimated 
that more than 100 genes might be involved (7), Approximately 
75% of pre-lingual deafness has an autosomal recessive mode 
of inheritance, and only about 25% an autosomal dominant 
mode of transmission (1). No comparable data are available 
for post-lingual hereditary hearing loss, and its frequency and 
mode of inheritance are inadequately known.
No gene has been identified yet for hereditary hearing loss, 
but the number of genes that have been localized has increased 
rapidly over the last year. The first gene, DFNA1, was localized 
to chromosome 5 in 1992 (8). In 1994 and 1995, five 
additional genes were assigned to chromosome 1 (DFNA2) 
(9), chromosome 19 (DFNA4) (10), chromosome 13 (DFNB1 
and DFNA3) (11,12), chromosome Í1 (DFNB2) (13), and 
chromosome 17 (DFNB3) (14), respectively.
In this study we have performed a gene localization in an 
extended Dutch family with autosomal dominant progressive 
hearing loss, starting in the high frequencies. After exclusion 
of linkage to known loci for hereditary hearing loss, this new 
locus (DFNA5) was localized to chromosome 7p,
*To whom correspondence should be addressed
2160 Human Molecular Genetics, 1995, VoL 4, No. II
RESULTS
Family pedigree
In 1966, 1972 and 1983 an extended Dutch family with 
hereditary hearing loss was described by Huizing et ciL 
(15-20). The family comprises five generations affected by 
progressive sensorineural hearing loss beginning in the high 
frequencies. The pattern of inheritance is autosomal dominant 
with complete penetrance. At the last follow-up study, 104 
descendants were found to be affected (18-20), No associated 
abnormalities were found in this family, indicating that the 
hearing loss is non-syndromic. The age of onset of the hearing 
loss is between 5-15 years. In the early phases of hearing 
deterioration, high frequency sensitivity is lost with thresholds 
dropping to 80 dB above 1000 Hz, while hearing at lower 
frequencies still remains normal. With increasing age and 
progressive high tone loss, the low frequencies become
Figure 1. Part of the pedigree with autosomal dominant hearing loss that was 
used for linkage analysis. Only family members whose DNA was studied, are 
numbered. Individuals neccssary to reconstruct the pedigree are shown without 
number. Affected individuals are represented by solid symbols.
affected. Around the age of 40-50 years, the low frequencies 
are also severely impaired. Vestibular functions are not affected 
and there are no complaints of tinnitus.
Genome search
Linkage to the five published loci for non-syndromic hearing 
loss was investigated in a first attempt to localize the gene. 
The loci on chromosome 5 (DFNA1) and chromosome 1 
(DFNA2) had been excluded previously (9). To exclude 
the other four loci, DFNA4, DFNB1, DFNB2 and DFNB3, 
respectively, genetic markers flanking these loci were analyzed. 
Each of these four loci could be excluded with lod scores 
below - 2  over the complete candidate region (results not 
shown).
To perform a genome search, a subset of 31 family members 
was selected that gave conclusive lod scores in simulated 
linkage analysis using the computer program SLINK (21). A 
genome search using a set of polymorphic simple tandem 
repeats covering the complete genome (22) was initiated, A 
total of 111 markers, which excluded 51% of the genome, 
were analyzed before a marker was found that gave a positive 
lod score above +3. With marker D7S513, a maximum lod 
score of 4.94 at 0% recombination was obtained.
Linkage to chromosome 7p
Marker D7S513 was subsequently typed on all the other family 
members that were not part of the initial subset used in the 
genome search. The total pedigree that was used for the linkage 
analysis is shown in Figure 1. Sixteen additional markers 
spanning a large region around D7S513, were subsequently 
analyzed. Two-point lod scores were calculated for all markers 
(Table 1). Their position on the Genethon genetic map (23) is 
shown in Figure 2. Positive lod scores above +3 were present 
for markers from a broad region. For markers D7S629, D7S682, 
D7S673, D7S529 and D7S516, maximum lod scores of 7.00, 
7.98, 13.53, 4.47 and 10.07 respectively were obtained at 0% 
recombination, indicating that these markers are closely linked 
to DFNA5.
The most likely haplotype for all 17 markers analyzed 
(Table 1) was constructed. No evidence for non-penetrance or
Table 1. Two-point lod scores between hearing loss and chromosome 7 markers
Locus Recombination fraction (0) 7*-mnx (0)
0.00 0.01 0.05 0.10 0.20 0.30 0.40
D7S517 -6.93 -3.49 -0 .44 1.00 1.80 1.50 0.63 1.81 (0.2 1 )
D7S513 3.54 4.37 5.76 6.13 5.49 4.01 1.96 6.13 (0. 10)
D7S664 4.99 5.42 6.04 6.01 5.05 3.50 1.59 6.09 (0.07)
D7S507 7.07 7.55 8.16 8.00 6.71 4.75 2.30 8.18 (0.06)
D7S503 6.35 7.12 7.93 7.83 6.58 4.65 2.24 7.96 (0.06)
D7S488 4.41 4.78 5.29 5.24 4.43 3.15 1.55 5.32 (0.06)
D7S654 0.79 0.84 0.96 0.97 0.83 0.60 0.31 0.97 (0.08)
D7S493 8.13 8.14 7.86 7.26 5.74 3.94 1.86 8.14 (0.0 1 )
D7S629 7.00 6.88 6.40 5.77 4.43 2.99 1.43 7.00 (0.00)
D7S682 7.98 7.85 7.33 6.65 5.20 3.57 1.76 7.98 (0.00)
D7S673 13.53 13.33 12.43 11.27 8.77 5.98 2.85 13,53 (0.00)
D7S529 4.47 4.39 4.05 3.61 2.70 1.72 0.71 4.47 (0.00)
D7S516 10.07 9.91 9.26 8.40 6.57 4.55 2.28 10.07 (0.00)
D7S632 4.87 5.14 5.49 5.37 4.43 3.03 1.32 5.50 (0.06)
D7S526 0.49 2.55 4.33 4.87 4.51 3.30 1.59 4.90 (0. 11 )
D7S690 -0.18 0.36 1.37 1.79 1.79 1.34 0.64 1.88 (0.15)
D7S683 -3.57 -2.49 -0.76 0.08 0.63 0.60 0.30 0.67 (0.24)
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phenocopies was present. Informative crossovers defining the 
interval containing DFNA5 were identified. Several recombina­
tions with the seven most telomeric markers (D7S517-D7S654)
tel
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Figure 2. Genetic map of the region surrounding DFNA5. The genetic map 
was obtained from G6nethon (23), Marker D7S513 is not present on the 
Genethon map, but is located beLween D7S517 and D7S664, according to the 
Cooperative Human Linkage Center (CHLC) map (33). Markers D7S673 and 
D7S632 have been mapped to chromosome band 7pl5 by in situ hybridization 
(34). Genetic distances between markers are indicated in cM next to the map.
were found, localizing DFNA5 centromeric to these markers. 
A single informative crossover with D7S493 is present in 
patient IV-16, placing DFNA5 centromeric to this marker. No 
recombination was observed with D7S629, D7S682, D7S673, 
D7S529 and D7S516. One informative crossover in affected 
individual III-4, and three informative crossovers in unaffected 
individuals III-7, 111-33, and IV-18 are present with D7S632, 
placing DFNA5 telomeric to this marker. This was confirmed 
by the finding of several recombinations with each of the three 
most centromeric markers D7S526, D7S690 and D7S683. A 
graphical representation of the key recombinations with the 
most closely linked markers is presented in Figure 3. The key 
recombinations indicate that the gene for hearing loss is most 
likely located in a 15 cM region between D7S493 and D7S632.
DISCUSSION
The Dutch family with hereditary hearing loss that was 
investigated in this study is one of the largest families with 
hereditary hearing loss ever reported with more than 100 
affected patients (15-20). For many years this family has been 
a reference family for autosomal dominant hearing loss of the 
high frequencies in the Mendelian Inheritance in Man catalogue
(MIM 124800) (4).
We performed a genome search to localize the gene respons­
ible for hearing loss, and found linkage with markers located 
on chromosome 7p. A region of 15 cM was defined between
telom ere
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Figure 3. Key recombinations between DFNA5 and chromosome 7 markers. The most important recombinational events between DFNA5 and 9 chromosome 
7p markers from the DFNA5 region are given as haplotypes next to the genetic map. Genetic distances between markers are given in cM. For each haplotype 
informative alleles are indicated by circles: black circles indicate chromosomal regions that contain DFNA5, and open circles indicate chromosomal regions 
from which DFNA5 is excluded. Allele numbers without circle are uninformative. The localization of DFNA5 by each recombinant is indicated by an arrow. 
The pedigree number and affection status is given below each haplotype. In conclusion, the key crossovers indicate that DFNA5 is most likely located in a 15
cM region between markers D7S493 and D7S632.
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markers D7S493 and D7S632 that most likely contains the 
gene responsible for hearing loss (DFNA5) in this family. A  
candidate region of 15 cM seems large for a family comprising 
more than 50 meiotic events. This is mainly the consequence 
of the limited number of markers that are available in this 
region, and the fact that some of these markers were hardly 
informative in the key recombinants (Fig. 3). The availability 
of new informative markers will most likely reduce the 
candidate region further.
The genes for two autosomal dominant progressive degener­
ative eye diseases, degenerative cystoid macular dystrophy 
(DCMD) and a form of retinitis pigmentosa (RP9) have been 
mapped to regions that overlap with the candidate region for 
DFNA5 (24,25). It must be noted that Usher syndrome, a 
syndromic form of hereditary hearing loss, is characterized by 
a combination of hearing loss and retinitis pigmentosa. In 
addition, a locus for non-syndromic deafness on chromosome
11 (DFNB2) is localized to the same region as a form of 
Usher syndrome (13). Although it is theoretically possible that 
DFNA5, RP9, and DCMD are caused by different mutations 
in the same gene, it is perhaps more likely that these three 
genes map to the same interval by chance. Amphiphysin 
(AMPH), a protein peripherally associated with synaptic 
vesicles (26), has been suggested as a candidate gene for RP9 
and DCMD as it has been mapped to this region by FISH 
(26). However, as a more precise localization o f  AMPH is 
lacking, it remains unknown whether AMPH is located in the 
candidate region of RP9, DCMD or DFNA5. A number of 
other genes are located in 7p l5  (4), including aquaporin 
(AQP1), a water selective transmembrane channel (27). How­
ever, the precise genetic localization of AQP1 proximal of 
D7S632 (28) excludes this gene as a candidate gene for 
DFNA5.
It is widely believed that there is a lack of suitable 
families with hereditary deafness in the Western world, as deaf 
individuals very frequently intermarry in the Western world. 
This assortative mating introduces several deafness genes 
into one family, thereby impairing gene localization studies. 
However, for dominant progressive hearing loss there is no 
assortative mating because significant hearing loss is only 
present in mid-life. Large families of this type have been 
described in countries all over the world, including the Western 
world. It is our personal experience that this type of hereditary 
hearing loss is even more frequent than can be estimated from 
the literature, and might be the most frequent form of genetic 
hearing impairment. Therefore, extended families with domin­
ant progressive hearing loss form an excellent opportunity to 
identify genes causing hearing loss. Further study of these 
genes can provide more insight in the process of progressive 
hearing loss, and may be important for an understanding of 
the very frequent hearing loss in adulthood.
MATERIALS AND METHODS
Family data
Part of the family was restudied at the time of blood sampling for the linkage 
analysis. Otoscopic and audiometric examinations were performed on 88 
family members. Pure tone audiometry was performed at 250, 500, 1000, 
2000, 4000, 6000, and 8000 Hz for air conduction, and at 500, 1000, 2000 
and 4000 Hz for bone conduction. In addition, clinical data and audiograms 
from all previous examinations were reanalyzed. Family members with a 
typical bilateral sensorineural hearing loss o f the high tones below the 95th 
percentile of an age and sex-dependent control audiometric curve (29) were
considered to be affected. Family members over the age of 15 were considered 
to be unaffected if the hearing thresholds at all frequencies were better than 
the 50th percentile of the age-dependent control curve. Individuals at risk 
under the age of 15, persons with hearing loss suspected to be due to non- 
genetic causes, or family members with a conductive hearing loss or an 
audiometric curve atypical for the family, were excluded from the linkage 
analysis. In total, linkage analysis was performed on 68 family members, 
including 36 affected patients.
Genetic analysis
Genomic DNA was extracted by standard techniques. Markers not present in 
the fluorescent mapping panel (22) were analyzed radioactively using standard 
procedures (30). For the genome search, simple tandem repeat polymorphisms 
were amplified using a fluorescently labeled primer and analyzed on an Applied 
Biosystems (ABI) DNA sequencer model 373A as described previously (22).
Fragment sizes of the marker alleles were calculated using the GENESCAN 
672 (version 1.2, ABI) software. Data were subsequently exported to the 
GENOTYPER (version 1,1, ABI) software package. A table containing the 
allele fragment sizes was exported from GENOTYPER as a text file. The 
data were further handled using the GENOME SEARCHER computer program 
(Van Camp et aL, unpublished). GENOME SEARCHER was used as an 
interface between GENOTYPER, the LINKAGE and FASTLINK computer 
programs (31,32), and a commercial computer program for pedigree drawing 
(CYRILLIC, Cherwell Scientific).
Linkage parameters
Linkage analysis was performed using the software package LINKAGE 
version 5.1. (31), and the FASTLINK computer program (32). The gene 
frequency for hearing loss due to mutations in this gene was set at 0.0001. 
For progressive hearing loss with adult onset, the clinical diagnosis causes 
specific problems. As hearing loss is frequent in the general population, non­
gene carrying family members may be present with a hearing impairment that 
cannot be distinguished from gene-carrying family members, giving rise to 
phenocopies. Also certain gene-carrying individuals may only be mildly 
affected and may incorrectly be diagnosed as unaffected, giving rise to non­
penetrance. It is our personal experience that phenocopies and non-penetrance 
occasionally occur in families with progressive hearing loss. Therefore, 
penetrance was arbitrarily set at 98% for heterozygotes to allow for non­
penetrance, and 2% for normal homozygotes to allow for possible phenocopies. 
Recombination frequencies were assumed to be equal for males and females. 
Allele frequencies were set equal to each other.
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